Nextbio Capital Management Lp Portfolio Stock Holdings

Nextbio Capital Management Lp disclosed 24 stock positions valued at approximately $215.4 million in its latest SEC 13F filing. The largest holdings include TERNS PHARMACEUTICALS INC, PROTAGONIST THERAPEUTICS INC, and SHATTUCK LABS INC. The filing reflects positions held as of March 31, 2026 and was filed on May 14, 2026.

Report Period
March 31, 2026
No. of Stocks
24
Portfolio Value
$215.4M
Holdings by Sector
Nextbio Capital Management Lp Portfolio Holdings in Q1 2026

17 holdings in the latest reporting period.

Page 1 of 1
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
TERNS PHARMACEUTICALS INCTERNHealthcare14.80%604,534+53,344+9.68%$31,871,032
PROTAGONIST THERAPEUTICS INCPTGXHealthcare11.24%229,619--$24,201,843
SHATTUCK LABS INCSTTKHealthcare9.40%3,149,907--$20,253,902
COMPASS PATHWAYS PLCCMPSHealthcare5.19%2,021,407+1,268,776+168.58%$11,178,381
RHYTHM PHARMACEUTICALS INCRYTMHealthcare5.09%126,078+58,492+86.54%$10,965,004
XENON PHARMACEUTICALS INCXENEHealthcare4.95%183,225-479-0.26%$10,654,534
VERASTEM INCVSTMHealthcare3.22%1,306,800-530-0.04%$6,926,040
ORIC PHARMACEUTICALS INCORICHealthcare3.08%523,619-92,101-14.96%$6,634,253
STRUCTURE THERAPEUTICS INCGPCRHealthcare2.98%133,239+38,796+41.08%$6,422,120
VAXCYTE INCPCVXHealthcare2.57%95,223-262-0.27%$5,533,409
COGENT BIOSCIENCES INCCOGTHealthcare2.34%131,188+35,369+36.91%$5,049,426
COMPASS THERAPEUTICS INCCMPXHealthcare2.08%848,204-265,801-23.86%$4,486,999
OCULIS HOLDING AGH5870P102Other1.85%149,592-158-0.11%$3,977,651
ZAI LAB LTDZLABHealthcare1.60%183,362+20,000+12.24%$3,449,039
DISC MEDICINE INCIRONHealthcare1.56%52,655+9,877+23.09%$3,366,761
KALVISTA PHARMACEUTICALS INCKALVHealthcare1.23%131,796--$2,653,053
SUMMIT THERAPEUTICS INCSMMTHealthcare0.79%89,717+89,717+100.00%$1,701,034